Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Modine Manufacturing
MOD
$10.4B
| $119K | ﹤0.01% |
6,577
-4,961
| -43% | -$93.1K |
|
|
BCOV
5027
DELISTED
Brightcove, Inc.
BCOV
| $119K | ﹤0.01% |
12,426
+5,060
| +69% | +$46.7K |
|
|
HOME
5028
DELISTED
At Home Group Inc.
HOME
| $119K | ﹤0.01% |
3,056
-8,643
| -74% | -$310K |
|
|
AL
5029
PUT
DELISTED
Air Lease Corp
AL
| $118K | ﹤0.01% |
2,800
-400
| -13% | -$17.3K |
|
5030
CALL
Helen of Troy
HELE
$675M
| $118K | ﹤0.01% |
1,200
-5,800
| -83% | -$529K |
|
5031
CALL
MannKind Corp
MNKD
$1.24B
| $118K | ﹤0.01% |
62,140
-82,600
| -57% | -$155K |
|
|
GHDX
5032
DELISTED
Genomic Health, Inc.
GHDX
| $118K | ﹤0.01% |
2,342
-5,757
| -71% | -$228K |
|
|
ADVM
5033
DELISTED
Adverum Biotechnologies
ADVM
| $117K | ﹤0.01% |
2,216
-7,372
| -77% | -$443K |
|
5034
Axsome Therapeutics
AXSM
$10.9B
| $117K | ﹤0.01% |
36,500
+900
| +3% | +$2.79K |
|
5035
PUT
Banc of California
BANC
$3.04B
| $117K | ﹤0.01% |
6,000
-1,000
| -14% | -$19.1K |
|
5036
Caesarstone
CSTE
$76.4M
| $117K | ﹤0.01% |
7,791
-125
| -2% | -$2.14K |
|
|
DESP
5037
DELISTED
Despegar.com
DESP
| $117K | ﹤0.01% |
5,600
-3,720
| -40% | -$95.8K |
|
5038
Erie Indemnity
ERIE
$13.3B
| $117K | ﹤0.01% |
994
-192
| -16% | -$22.2K |
|
5039
CALL
Gyre Therapeutics
GYRE
$705M
| $117K | ﹤0.01% |
+1,333
| New | +$234K |
|
|
NVEE
5040
DELISTED
NV5 Global
NVEE
| $117K | ﹤0.01% |
6,744
-244
| -3% | -$3.8K |
|
5041
CALL
Precigen
PGEN
$2.49B
| $117K | ﹤0.01% |
8,400
-1,700
| -17% | -$28.7K |
|
5042
CALL
ProShares Ultra Semiconductors
USD
$2.87B
| $117K | ﹤0.01% |
43,200
-9,600
| -18% | -$27.6K |
|
|
ZVO
5043
DELISTED
Zovio Inc. Common Stock
ZVO
| $117K | ﹤0.01% |
18,027
+12,045
| +201% | +$77.4K |
|
|
ILPT
5044
Industrial Logistics Properties Trust
ILPT
$565M
| $116K | ﹤0.01% |
5,178
+999
| +24% | +$21.2K |
|
5045
PUT
Waters Corp
WAT
$38.8B
| $116K | ﹤0.01% |
+600
| New | +$118K |
|
5046
CALL
Essential Utilities
WTRG
$11.3B
| $116K | ﹤0.01% |
3,300
+1,000
| +43% | +$34.3K |
|
|
CURO
5047
DELISTED
CURO Group Holdings Corp.
CURO
| $116K | ﹤0.01% |
4,667
+3,065
| +191% | +$67.3K |
|
|
ASNA
5048
PUT
DELISTED
Ascena Retail Group, Inc.
ASNA
| $116K | ﹤0.01% |
1,460
+1,115
| +323% | +$67.4K |
|
5049
CALL
Cheniere Energy
CQP
$32B
| $115K | ﹤0.01% |
3,200
-7,200
| -69% | -$237K |
|
|
AVEO
5050
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $115K | ﹤0.01% |
5,100
-5,770
| -53% | -$137K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.